Oechsle, C.M.; Showalter, L.E.; Novak, C.M.; Czerniecki, B.J.; Koski, G.K.
Statin Drugs Plus Th1 Cytokines Potentiate Apoptosis and Ras Delocalization in Human Breast Cancer Lines and Combine with Dendritic Cell-Based Immunotherapy to Suppress Tumor Growth in a Mouse Model of HER-2pos Disease. Vaccines 2020, 8, 72.
https://doi.org/10.3390/vaccines8010072
AMA Style
Oechsle CM, Showalter LE, Novak CM, Czerniecki BJ, Koski GK.
Statin Drugs Plus Th1 Cytokines Potentiate Apoptosis and Ras Delocalization in Human Breast Cancer Lines and Combine with Dendritic Cell-Based Immunotherapy to Suppress Tumor Growth in a Mouse Model of HER-2pos Disease. Vaccines. 2020; 8(1):72.
https://doi.org/10.3390/vaccines8010072
Chicago/Turabian Style
Oechsle, Crystal M., Loral E. Showalter, Colleen M. Novak, Brain J. Czerniecki, and Gary K. Koski.
2020. "Statin Drugs Plus Th1 Cytokines Potentiate Apoptosis and Ras Delocalization in Human Breast Cancer Lines and Combine with Dendritic Cell-Based Immunotherapy to Suppress Tumor Growth in a Mouse Model of HER-2pos Disease" Vaccines 8, no. 1: 72.
https://doi.org/10.3390/vaccines8010072
APA Style
Oechsle, C. M., Showalter, L. E., Novak, C. M., Czerniecki, B. J., & Koski, G. K.
(2020). Statin Drugs Plus Th1 Cytokines Potentiate Apoptosis and Ras Delocalization in Human Breast Cancer Lines and Combine with Dendritic Cell-Based Immunotherapy to Suppress Tumor Growth in a Mouse Model of HER-2pos Disease. Vaccines, 8(1), 72.
https://doi.org/10.3390/vaccines8010072